prod:prod_dcx-login
Xpert® MTB/XDR
Simplifying TB drug susceptibility testing utilizing increased multiplexing capability with 10 color GeneXpert® technology
Sign in or create a MyCepheid account to add items to cart
Test pack size(s)
10 Tests
GXMTB/XDR-10
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Total
{{currency}}
0
Error adding items to cart. If this error persists, please contact Digital Support
The Need
- In 2022, only 43% of the total estimated multidrug-resistant Tuberculosis (MDR-TB) incident cases were diagnosed and enrolled on treatment regimen1
- Only 47% of the total notified MDR-TB cases were tested for resistance to fluoroquinolones1
- Increase access to rapid and extended drug resistance profiling for all TB-positive cases to rule out MDR/pre-XDR^ TB2
1 World Health Organization Tuberculosis Report 2023--https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2023/tb-disease-burden/1-3-drug-resistant-tb. Accessed January 2024.
2 Global Plan to End TB, STOP TB Report- https://omnibook.com/api/export/1.0/dc664b3a-14b4-4cc0-8042-ea8f27e902a6/-1/0/pdf^ Pre-XDR: Pre-Extensive Drug Resistant TB
^ Pre-XDR: Pre-Extensive Drug Resistant TB
2 Global Plan to End TB, STOP TB Report- https://omnibook.com/api/export/1.0/dc664b3a-14b4-4cc0-8042-ea8f27e902a6/-1/0/pdf^ Pre-XDR: Pre-Extensive Drug Resistant TB
^ Pre-XDR: Pre-Extensive Drug Resistant TB
The Solution
The Xpert MTB/XDR test enables rapid molecular DST. When combined with the frontline Xpert MTB/RIF Ultra test, it sets new standards by detecting mutations associated with resistance to isoniazid (INH), fluoroquinolones (FLQ), second-line injectable drugs (SLIDs), and ethionamide (ETH) in a single test.
- Fast time to result for molecular DST
- Results in <90 minutes
- Same easy-to-use process as the Xpert MTB/RIF Ultra test
- Run on existing GeneXpert® platforms equipped with 10-color modules
The Impact
- Upfront molecular DST for all TB-positive cases enables optimized treatment in a single visit
- Increased access to drug-resistance testing with Xpert MTB/XDR help notify more people affected with MDR and Pre-XDR TB3
- The Xpert MTB/XDR assay provides the capability to differentiate between high and low-level resistance to INH and FLQ, which is important for determining therapeutic options and individualized treatment regimens4
3 Adam Penn-Nicholson et al. 2022 https://www.medrxiv.org/content/10.1101/2021.05.06.21256505v1.full.pdf
4 L Saderi, et al. 2022 https://www.archbronconeumol.org/es-pdf-S0300289622004987
4 L Saderi, et al. 2022 https://www.archbronconeumol.org/es-pdf-S0300289622004987
Related Products
Xpert HCV Viral Load
Highly sensitive, timely results for effective patient management and improved access to testing.
Xpert MTB/RIF Ultra
Enhanced performance in detecting drug-sensitive and -resistant Tuberculosis in less than 80 minutes
Xpert HIV-1 Qual
Detection of Human Immunodeficiency Virus Type 1 (HIV-1) in around 90 minutes
Xpert HIV-1 Viral Load
Dual Target Detection for Extended Coverage and Superior Performance